An acceptability and safety study of the Duet® cervical barrier and gel delivery system in Zimbabwe

Journal of the International AIDS Society

Volumn 13, Issue 1, 2010, Pages

  Montgomery, Elizabeth T ^a   Woodsong, Cynthia ^b   Musara, Petina ^c   Cheng, Helen ^a   Chipato, Tsungai ^c   Moench, Thomas R ^d   Spielberg, Freya ^a   Van Der Straten, Ariane ^a,e  

^a RTI INTERNATIONAL   (United States)

^b INTERNATIONAL PARTNERSHIP FOR MICROBICIDES   (United States)

^c UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^d REPROTECT INC   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUBRICATING AGENT;

ADULT; ARTICLE; BARRIER CONTRACEPTION; CERVICAL BARRIER; CLINICAL ASSESSMENT; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIAPHRAGM; FEMALE; FOLLOW UP; GYNECOLOGIC DISEASE; HUMAN; INFECTION PREVENTION; INTERVIEW; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SAFE SEX; SAFETY; SEXUAL BEHAVIOR; URINARY TRACT DISEASE; ZIMBABWE; ADOLESCENT; FEMALE CONTRACEPTIVE DEVICE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT SATISFACTION; PSYCHOLOGICAL ASPECT; UTILIZATION REVIEW;

ADOLESCENT; ADULT; CONTRACEPTIVE DEVICES, FEMALE; FEMALE; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE; PATIENT SATISFACTION; SAFE SEX; YOUNG ADULT; ZIMBABWE;

EID: 77957104309     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-13-30     Document Type: Article

References (30)

1. UNAIDS, Report on the global AIDS epidemic: executive summary. Geneva 2008
2. Persisting with prevention: The importance of adherence for HIV prevention. HA Weiss JN Wasserheit RV Barnabas RJ Hayes LJ Abu-Raddad, Emerging Themes in Epidemiology 2008 5 8 10.1186/1742-7622-5-8 18620578
3. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. NS Padian A van der Straten G Ramjee T Chipato G de Bruyn K Blanchard S Shiboski ET Montgomery H Fancher H Cheng M Rosenblum M van der Laan N Jewell J McIntyre, Lancet 2007 370 251 261 10.1016/S0140-6736(07)60950-7 17631387
4. Efficacy dilution in randomized placebo-controlled vaginal microbicide trials. B Msse M Boily D Dimitrov K Desai, Emerg Themes Epidemiol 2009 6 5 10.1186/1742-7622-6-5 19818138
5. Vaginal Microbicide and Diaphragm Use for Sexually Transmitted Infection Prevention: A Randomized Acceptability and Feasibility Study Among High-Risk Women in Madagascar. F Behets A Turner K Van Damme L Rabenja N Ravelomanana T Swezey, Sex Transm Dis 2008 35 818 826 10.1097/OLQ.0b013e318175d8ab 18562985
6. Acceptability and feasibility of continuous diaphragm use among sex workers in Madagascar. F Behets A Turner K Van Damme N Rabenja N Ravelomanana K Zeller J Rasolofomanana, Sex Transm Infect 2005 81 472 476 10.1136/sti.2005. 015107 16326849
7. The rate at which human sperm are immobilized and killed by mild acidity. SS Olmsted NH Dubin RA Cone TR Moench, Fertil Steril 2000 73 687 693 10.1016/S0015-0282(99)00640-8 10731526
8. Tests of BufferGel for contraception and prevention of sexually transmitted diseases in animal models. L Zeitlin TE Hoen SL Achilles TA Hegarty AE Jerse JW Kreider SS Olmsted KJ Whaley RA Cone TR Moench, Sex Transm Dis 2001 28 417 423 10.1097/00007435-200107000-00010 11460027
9. Safety and efficacy evaluations for vaginal and rectal use of BufferGel in the macaque model. DL Patton YC Sweeney PK Cummings L Meyn LK Rabe SL Hillier, Sex Transm Dis 2004 31 290 296 10.1097/01.OLQ.0000124614.91448.D4 15107631
10. Phase 1 trial of the topical microbicide BufferGel: safety results from four international sites. J van de Wijgert A Fullem C Kelly S Mehendale S Rugpao N Kumwenda Z Chirenje S Joshi T Taha N Padian R Bollinger K Nelson, J Acquir Immune Defic Syndr 2001 26 21 27 11176265
11. Safety and acceptability of penile application of 2 candidate topical microbicides: BufferGel and PRO 2000 Gel-3 randomized trials in healthy low-risk men and HIV-positive men. SR Tabet MM Callahan CK Mauck F Gai AS Coletti AT Profy TR Moench LE Soto-Torres AN Poindexter RG Frezieres TL Walsh CW Kelly BA Richardson L van Damme CL Celum, Journal of Acquired Immune Deficiency Syndromes 2003 33 476 483 12869836
12. Trial finds microbicide promising as HIV prevention method for Women. MTN, Press Release 2009
13. Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial. KT Barnhart MJ Rosenberg HT MacKay DL Blithe J Higgins T Walsh L Wan M Thomas MD Creinin C Westhoff W Schlaff DF Archer C Ayers A Kaunitz S Das TR Moench, Obstet Gynecol 2007 110 577 586 17766603
14. A Phase 1 study of the functional performance, safety, and acceptability of the BufferGel Duet. S Ballagh V Brache C Mauck M Callahan L Cochon A Wheeless T Moench, Contraception 2007 77 130 137 10.1016/j.contraception.2007.10.003 18226678
15. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. NS Padian A van der Straten G Ramjee T Chipato G de Bruyn K Blanchard S Shiboski ET Montgomery H Fancher H Cheng, The Lancet 2007 370 251 261 10.1016/S0140-6736(07)60950-7
16. Duet for menstrual protection: a feasibility study in Zimbabwe. S Averbach N Sahin-Hodoglugil P Musara T Chipato A van der Straten, Contraception 2009 79 463 468 10.1016/j.contraception.2008.12.002 19442783
17. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. RP Nugent MA Krohn SL Hillier, J Clin Microbiol 1991 29 297 301 1706728
18. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. R Amsel PA Totten CA Spiegel KC Chen D Eschenbach KK Holmes, Am J Med 1983 74 14 22 10.1016/0002-9343(83)91112-9 6600371
19. Welfare MoHaC, EDLIZ: Essential Drugs List for Zimbabwe, including guidelines for treatment of medical conditions common in Zimbabwe Harare: National Drug and Therapeutics Policy Advisory Committee 3 1994
20. Promoting continuous use as a strategy for achieving adherence in a trial of the diaphragm with candidate microbicide. A Penman-Aguilar T Swezey A Norris Turner A Bell F Ramiandrisoa J Legardy-Williams B Randrianasolo K Van Damme J Dulyx F Behets D Jamieson, AIDS Educ and Prev 2009 21 512 525 10.1521/aeap.2009.21.6.512
21. "I think condoms are good but, aai, I hate those things": condom use among adolescents and young people in a Southern African township. C MacPhail C Campbell, Soc Sci Med 2001 52 1613 1627 10.1016/S0277-9536(00)00272-0 11327136
22. Promoting protection and pleasure: amplifying the effectiveness of barriers against sexually transmitted infections and pregnancy. A Philpott W Knerr D Maher, Lancet 2006 368 2028 2031 10.1016/S0140-6736(06)69810-3 17141710
23. Sexual Pleasure, Gender Power and Microbicide Acceptability in Zimbabwe and Malawi. C Woodsong P Alleman, AIDS Education & Prevention 2008 20 171 187
24. Acceptability research on female-controlled barrier methods to prevent heterosexual transmission of HIV: Where have we been? Where are we going? C Elias C Coggins, J Women's Health Gend Based Med 2001 10 163 173 10.1089/152460901300039502
25. Acceptability and use of the diaphragm and Replens® lubricant gel for HIV prevention in Southern Africa. E Montgomery H Cheng A van der Straten A Chidanyika N Lince K Blanchard G Ramjee B Nkala N Padian, AIDS and Behaviour 2010 14 3 629 638 10.1007/s10461-009-9609-z
26. Female-controlled HIV prevention methods in Zimbabwe: how "involved" are the male partners? [oral presentation]. E Montgomery A Chidanyika S Mtetwa T Chipato N Padian A van der Straten, 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention; 22-25 July 2007; Sydney, Australia
27. Consistent use of a combination product versus a single product in a safety trial of the diaphragm and microbice in Harare, Zimbabwe. A van der Straten J Moore S Napierala K Clouse C Mauk N Hammond N Padian, Contraception 2008 77 435 443 10.1016/j.contraception.2008.02.013 18477494
28. Women's acceptance of the diaphragm: the role of relationship factors. LJ Beckman SM Harvey S Thorburn JE Maher KL Burns, J Sex Res 2006 43 297 306 10.1080/00224490609552329 17599251
29. Diaphragm and lubricant gel acceptance, skills and patterns of use among women in an effectiveness trial in Southern Africa. ET Montgomery K Blanchard H Cheng T Chipato G deBruyn G Ramjee NS Padian A van der Straten MIRA team, Eur J Contracept Reprod Health Care 2009 14 410 419 10.3109/13625180903215430 19929644
30. HIV incidence among women of reproductive age in Malawi and Zimbabwe. N Kumwenda I Hoffman M Chirenje C Kelly A Coletti A Ristow F Martinson J Brown D Chilongozi B Richardson Z Rosenberg N Padian T Taha, Sex Transm Dis 2006 33 646 651 10.1097/01.olq.0000223283.27142.9f 16773032